Systematic Biology Study for Lung Cancer and Tuberculosis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040666

Enrollment

Unknown

Registered

2020-12-07

Start date

2019-11-05

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer and Tuberculosis

Interventions

Normal control group:Nil

Lung Cancer: Nil

Tuberculosis: Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients who meet the relevant diagnostic criteria for tuberculosis and lung cancer and have obtained a clear diagnosis; 2) aged over 18 years old; 3) be informed about this study and participate voluntarily; 4) the selected tuberculosis patients are all newly treated.

Exclusion criteria

Exclusion criteria: 1) Other metabolic diseases, blood diseases, cancer; 2) Serious infection; 3) Serious cardiovascular, cerebrovascular, liver, and kidney dysfunction.

Design outcomes

Primary

Measure	Time frame
carcinoembryonic antigen;pathology;	—

Countries

China

Contacts

Public ContactYubo Li

Tianjin University of Traditional Chinese Medicine

yaowufenxi001@sina.com+86 15332130770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026